116 related articles for article (PubMed ID: 17453392)
1. A novel rat model for the study of deficits in bone formation in type-2 diabetes.
Liu Z; Aronson J; Wahl EC; Liu L; Perrien DS; Kern PA; Fowlkes JL; Thrailkill KM; Bunn RC; Cockrell GE; Skinner RA; Lumpkin CK
Acta Orthop; 2007 Feb; 78(1):46-55. PubMed ID: 17453392
[TBL] [Abstract][Full Text] [Related]
2. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
[TBL] [Abstract][Full Text] [Related]
3. The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat.
Shyng YC; Devlin H; Sloan P
Int J Oral Maxillofac Surg; 2001 Feb; 30(1):70-4. PubMed ID: 11289625
[TBL] [Abstract][Full Text] [Related]
4. Bone regeneration and fracture healing. Experience with distraction osteogenesis model.
Richards M; Goulet JA; Weiss JA; Waanders NA; Schaffler MB; Goldstein SA
Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S191-204. PubMed ID: 9917639
[TBL] [Abstract][Full Text] [Related]
5. Altered bone mass, geometry and mechanical properties during the development and progression of type 2 diabetes in the Zucker diabetic fatty rat.
Prisby RD; Swift JM; Bloomfield SA; Hogan HA; Delp MD
J Endocrinol; 2008 Dec; 199(3):379-88. PubMed ID: 18755885
[TBL] [Abstract][Full Text] [Related]
6. The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesis.
Ozkan K; Eralp L; Kocaoglu M; Ahishali B; Bilgic B; Mutlu Z; Turker M; Ozkan FU; Sahin K; Guven M
Growth Factors; 2007 Apr; 25(2):101-7. PubMed ID: 17891595
[TBL] [Abstract][Full Text] [Related]
7. Increased aldosterone levels in a model of type 2 diabetes mellitus.
Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats.
Jöhren O; Dendorfer A; Dominiak P; Raasch W
Brain Res; 2007 Dec; 1184():160-7. PubMed ID: 17945204
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis.
Haque T; Hamade F; Alam N; Kotsiopriftis M; Lauzier D; St-Arnaud R; Hamdy RC
Bone; 2008 Jun; 42(6):1144-53. PubMed ID: 18372226
[TBL] [Abstract][Full Text] [Related]
10. Bone associated with implants in diabetic and insulin-treated rats.
McCracken MS; Aponte-Wesson R; Chavali R; Lemons JE
Clin Oral Implants Res; 2006 Oct; 17(5):495-500. PubMed ID: 16958687
[TBL] [Abstract][Full Text] [Related]
11. The impact of total enteral nutrition on distraction osteogenesis in a rat model.
Lumpkin CK; Aronson J; Shen XC; Gao GG; Skinner RA; Badger TM
J Bone Miner Res; 1996 Jul; 11(7):962-9. PubMed ID: 8797117
[TBL] [Abstract][Full Text] [Related]
12. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats.
Follak N; Klöting I; Wolf E; Merk H
Bone; 2004 Jul; 35(1):144-52. PubMed ID: 15207750
[TBL] [Abstract][Full Text] [Related]
13. Experimental rat models to study the metabolic syndrome.
Aleixandre de Artiñano A; Miguel Castro M
Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
[TBL] [Abstract][Full Text] [Related]
15. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy.
Picke AK; Gordaliza Alaguero I; Campbell GM; Glüer CC; Salbach-Hirsch J; Rauner M; Hofbauer LC; Hofbauer C
Bone; 2016 Jan; 82():108-15. PubMed ID: 26055107
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
Topp BG; Atkinson LL; Finegood DT
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.
Hamann C; Rauner M; Höhna Y; Bernhardt R; Mettelsiefen J; Goettsch C; Günther KP; Stolina M; Han CY; Asuncion FJ; Ominsky MS; Hofbauer LC
J Bone Miner Res; 2013 Mar; 28(3):627-38. PubMed ID: 23109114
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
[TBL] [Abstract][Full Text] [Related]
19. Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation.
Choi IH; Ahn JH; Chung CY; Cho TJ
J Orthop Res; 2000 Sep; 18(5):698-705. PubMed ID: 11117289
[TBL] [Abstract][Full Text] [Related]
20. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
